Work

582 Cholesterol levels increase on elexacaftor-tezacaftor-ivacaftor therapy but remain within acceptable ranges

Year: 2023

Type: article

Study design: Observational Study

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(23)01504-7

Authors: R. Boyle, J. Xia, S. Patel, K. Ho, D. Lu, N. Lechtzin, C. Merlo, S. Allgood, N. West

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Monash University, Royal Hobart Hospital, University of Tasmania, Johns Hopkins Hospital

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387738533

FWCI: 0.183

Cites: 1

Cited by: 1

Related to: 10